USPTO serial 77384324
LIPIGEN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHARLON, BARNEY
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LIPIGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Ophthalmic preparations, eye drops, and medicated eye gels and medicated gels applied to the meibomian glands used for the treatment of ocular disorders, namely, dry eye and meibomian gland dysfunction | ACTIVE | — |
| 009 | Computer hardware and software, and parts and accessories therefor, for use with apparatus for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction | ACTIVE | — |
| 010 | Medical apparatuses and devices, and parts and accessories therefor, used for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; Medical devices, and parts and accessories therefor, for expressing obstructions or occlusions from meibomian glands; Medical heater used primarily for medical purposes, namely, for applying heat to a patient's eye and related eye structure for treating eye diseases, namely, dry eye and meibomian gland dysfunction; Medical devices, namely, medical contact lens used primarily for medical purposes containing an electrical heating element for applying heat to meibomian glands when installed on a patient's eye for treating dry eye and meibomian gland dysfunction; Optical and photographic apparatus and instruments, and parts and accessories therefor, namely, interferometers and cameras, for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; medical imaging apparatuses and devices comprising optical lens, camera, lamp, LED, spectrometer, used for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical temperature controller, and parts and accessories therefor, used primarily for temperature controller purposes, namely, for delivering and controlling heat to meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical pressure controller, and parts and accessories therefor, used primarily for controlling pressure, namely, for applying and controlling pressure to the meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical fluid transfer controller, and parts and accessories therefor, used primarily for controlling and transferring heated fluid to the eye for use in treating eye disease, namely, dry eye and meibomian gland dysfunction | ACTIVE | — |
| 016 | Printed instructional, educational and teaching materials in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Printed instructional, educational and teaching materials for analysis, diagnosis, treatment, and monitoring of eye disease, namely, dry eye and meibomian gland dysfunction | ACTIVE | — |
| 041 | Education services, namely, classes, conferences, seminars, workshops, in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Education services, namely, providing seminars, tutorials, workshops for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; Training services in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Training services, namely, providing seminars, tutorials, workshops for analyzing, diagnosing, treating, and monitoring eye disease, namely,dry eye and meibomian gland dysfunction | ACTIVE | — |
| 044 | Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of eye diseases and conditions; Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of dry eye and meibomian gland dysfunction; Providing medical information related to eye disease, namely, dry eye and meibomian gland dysfunction, for educational purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TEARSCIENCE, INC.
- Other trademarks owned by Kolis Scientific, Inc.
- Other trademarks owned by Kolis Scientific, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named LIPIGEN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 6, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 6, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 15, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 14, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 2, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 9, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 8, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 7, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 7, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 7, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 7, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 4, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 1, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 21, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 18, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 18, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jul 18, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 18, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 18, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 1, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 1, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 4, 2008 | NWAP | NEW APPLICATION ENTERED | — |